文献速递肿瘤 PET/CT放射性药物与辐射防护

定量PET/CT评估IgG4相关疾病治疗反应

Response to Treatment in IgG4-Related Disease Assessed by Quantitative PET/CT Scan.
PubMed 文献 · Clin Nucl Med · 2021-01-01

该回顾性研究纳入西班牙巴塞罗那单中心18例IgG4相关疾病(IgG4-RD)患者的23次 flare,在 flare 起始2周内及治疗至少3个月后行18F-FDG PET/CT,以IgG4-RD应答指数(IgG4-RI)为标准评估疗效。结果显示除病灶大小外,SUVmax、SUVmean、总病灶糖酵解、MTV及改良Deauville评分在随访时均显著降低,且多数参数与IgG4-RI正相关。

要点

  • IgG4-RD flare治疗后,PET/CT半定量、体积及视觉参数多显著降低。
  • 除SUVmean和病灶大小外,PET/CT参数与IgG4-RI正相关。
  • 体积和视觉指标受变异影响小,或可改进活动度评分和治疗策略。

核心结论

  • PET/CT半定量、体积及视觉参数与IgG4-RI评估的治疗反应相关,体积和视觉指标变异较小,可能有助于改进活动度评分和治疗策略。

研究设计与样本

  • 回顾性单中心研究,纳入西班牙巴塞罗那2012至2018年18例IgG4-RD患者的23次 flare,均在 flare 起始2周内及治疗至少3个月后行18F-FDG PET/CT。

主要发现

  • 根据IgG4-RI,20次 flare(87%)达到缓解(完全或部分)。
  • 随访时SUVmax、SUVmean、总病灶糖酵解、MTV及改良Deauville评分均显著低于基线,病灶大小除外。
  • 除SUVmean和病灶大小外,其他PET/CT参数与IgG4-RI呈正相关。

关键数值与推荐

  • 以IgG4-RI作为评估治疗反应的标准;第二次PET/CT中位时间为7个月。

临床怎么用

  • 对IgG4-RD flare患者,可在治疗前后行18F-FDG PET/CT,结合半定量、体积及视觉参数辅助评估治疗反应。

局限性

  • 回顾性单中心设计,样本量小(18例患者、23次 flare),结果需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to assess disease activity by different PET/CT measurements in IgG4-related disease (IgG4-RD) flares and their correlation with the IgG4-RD responder index (IgG4-RI). PATIENTS AND METHODS: Patients were retrospectively recruited from a single center in Barcelona, Spain. They all had IgG4-RD flares with an 18F-FDG PET/CT examination performed within the 2 first weeks of the flare onset and another one after at least 3 months of treatment between 2012 and 2018. Epidemiologic, clinical, laboratory, and therapeutic data were collected at baseline and at follow-up. Semiquantitative and volumetric measurements from PET/CT explorations were recorded. In addition, a 5-point visual scale was (adapted Deauville score) trialed. The IgG4-RI was used as the criterion standard to assess response before and after treatment. RESULTS: Eighteen patients with a total of 23 flares were included. The median time to second PET/CT examination was 7 months. Remission (complete and partial) according to IgG4-RI was observed in 20 flares (87%). All PET/CT measurements (SUVmax and SUVmean, total lesion glycolysis, MTV, and adapted Deauville score) were statistically significantly lower on the follow-up evaluation, except for the size of the lesion. The correlation of all these parameters with the IgG4-RI was positive except for SUVmean and the size of the lesion. CONCLUSIONS: Semiquantitative, volumetric, and visual parameters in PET/CT scans correlated with response to treatment assessed by IgG4-RI. Volumetric and visual items are less subject to variations and could be used to improve activity scores and treatment strategies.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Orozco-Gálvez O, Fernández-Codina A, Simó-Perdigo M, et al. Response to Treatment in IgG4-Related Disease Assessed by Quantitative PET/CT Scan. Clin Nucl Med. 2021. PMID: 33630792. doi:10.1097/RLU.0000000000003537

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。